Commentary: Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens von Llibre, Josep M, Cahn, Pedro E, Barber, Tristan J

Volltext

Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies... von Walmsley, Sharon, Smith, Don E, Górgolas, Miguel, Cahn, Pedro E, Lutz, Thomas, Lacombe, Karine, Kumar, Princy N, Wynne, Brian, Grove, Richard, Bontempo, Gilda, Moodley, Riya, Okoli, Chinyere, Kisare, Michelle, Jones, Bryn, Clark, Andrew, Ait-Khaled, Mounir

Volltext

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and old... von Halperin, Scott A, Ye, Lingyun, MacKinnon-Cameron, Donna, Smith, Bruce, Cahn, Pedro E, Ruiz-Palacios, Guillermo M, Ikram, Aamer, Lanas, Fernando, Lourdes Guerrero, M, Muñoz Navarro, Sergio Raúl, Sued, Omar, Lioznov, Dmitry A, Dzutseva, Vitalina, Parveen, Ghazala, Zhu, Fengcai, Leppan, Laura, Langley, Joanne M, Barreto, Luis, Gou, Jinbo, Zhu, Tao, Mao, Helen, Gagnon, Luc, Tran, Steven-Phay, Khan, Sarwat Tahsin, Becerra Aquino, Amalia Guadalupe, Saldaña Montemayor, Edgar Eduardo, Rivera Martínez, Norma Eréndira, Bohórquez López, Víctor Casildo, Simón Campos, J. Abraham, Pineda Cárdenas, Felipe de Jesús, Chen, Wei, Hou, Lihua, Zhang, Zhe, Corral, Gonzalo, López, Eduardo, Teijeiro, Ricardo, Alzogaray, Maria F., Zaidman, Cesar, Lopardo, Gustavo, Goecke, Bernardo, Feijooó Seoane, Rosa María, Mahmood, Sayed Faisal, Khan, Ejaz Ahmed, Akram, Jayed, Abbas, Salma, Salahuddin, Naseem, Rozhkova, Elena, Zubkova, Tatyana

Volltext

Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America von Cesar, Carina, Shepherd, Bryan E, Krolewiecki, Alejandro J, Fink, Valeria I, Schechter, Mauro, Tuboi, Suely H, Wolff, Marcelo, Pape, Jean W, Leger, Paul, Padgett, Denis, Madero, Juan Sierra, Gotuzzo, Eduardo, Sued, Omar, McGowan, Catherine C, Masys, Daniel R, Cahn, Pedro E

Volltext

Changes in Inflammatory and Atherogenesis Biomarkers With the 2-Drug Regimen Dolutegravir Plus Lamivudine in Antiretroviral Therapy–Experienced, Virologically Suppressed People Wit... von Llibre, Josep M, Cahn, Pedro E, Lo, Janet, Barber, Tristan J, Mussini, Cristina, van Welzen, Berend J, Hernandez, Beatriz, Donovan, Cynthia, Kisare, Michelle, Sithamparanathan, Myooran, van Wyk, Jean

Volltext

Liver cirrhosis in HIV/HCV‐coinfected individuals is related to NK cell dysfunction and exhaustion, but not to an impaired NK cell modulation by CD4+ T‐cells von Polo, María L, Ghiglione, Yanina A, Salido, Jimena P, Urioste, Alejandra, Poblete, Gabriela, Sisto, Alicia E, Martinez, Ana, Rolón, María J, Ojeda, Diego S, Cahn, Pedro E, Turk, Gabriela J, Laufer, Natalia L

Volltext

Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth von SZYLD, Edgardo G, WARLEY, Eduardo M, FREIMANIS, Laura, GONIN, René, CAHN, Pedro E, CALVET, Guilherme A, DUARTE, Geraldo, MELO, Victor H, READ, Jennifer S

Volltext

Atazanavir—A Once-daily HIV Protease Inhibitor That Does Not Cause Dyslipidemia in Newly Treated Patients: Results from Two Randomized Clinical Trials von Cahn, Pedro E., Gatell, José M., Squires, Kathleen, Percival, Lisa D., Piliero, Peter J., Sanne, Ian A., Shelton, Sarah, Lazzarin, Adriano, Odeshoo, Linda, Kelleher, Thomas D., Thiry, Alexandra, Giordano, Michael D., Schnittman, Stephen M.

Volltext

Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial von Lalezari, Jacob P, Dr, Latiff, Gulam H, MD, Brinson, Cynthia, MD, Echevarría, Juan, MD, Treviño-Pérez, Sandra, MD, Bogner, Johannes R, Prof, Thompson, Melanie, MD, Fourie, Jan, MD, Sussmann Pena, Otto A, MD, Mendo Urbina, Fernando C, MD, Martins, Marcelo, MD, Diaconescu, Iulian G, MD, Stock, David A, PhD, Joshi, Samit R, DO, Hanna, George J, MD, Lataillade, Max, DO

Volltext

HBV and HCV co-infections in HIV positive patients in the "HAART era": new challenges von Laufer, Natalia L, Quarleri, Jorge F, Bouzas, Maria B, Perez, Hector M, Salomon, Horacio, Cahn, Pedro E

Volltext

Liver cirrhosis in HIV / HCV ‐coinfected individuals is related to NK cell dysfunction and exhaustion, but not to an impaired NK cell modulation by CD 4 + T‐cells von Polo, María L, Ghiglione, Yanina A, Salido, Jimena P, Urioste, Alejandra, Poblete, Gabriela, Sisto, Alicia E, Martinez, Ana, Rolón, María J, Ojeda, Diego S, Cahn, Pedro E, Turk, Gabriela J, Laufer, Natalia L

Volltext

A Randomized, Controlled, Phase II Trial Comparing Escalating Doses of Subcutaneous Interleukin-2 plus Antiretrovirals versus Antiretrovirals Alone in Human Immunodeficiency Virus-... von Losso, Marcelo H., Belloso, Waldo H., Emery, Sean, Benetucci, Jorge A., Cahn, Pedro E., Lasala, Maria C., Lopardo, Gustavo, Salomon, Horacio, Saracco, Monica, Nelson, Eileen, Law, Matthew G., Davey, Richard T., Allende, Maria C., Lane, H. Clifford

Volltext

A Randomized, Controlled, Phase II Trial Comparing Escalating Doses of Subcutaneous Interleukin‐2 plus Antiretrovirals versus Antiretrovirals Alone in Human Immunodeficiency Virus–... von Losso, Marcelo H., Belloso, Waldo H., Emery, Sean, Benetucci, Jorge A., Cahn, Pedro E., Lasala, Maria C., Lopardo, Gustavo, Salomon, Horacio, Saracco, Monica, Nelson, Eileen, Law, Matthew G., Davey, Richard T., Allende, Maria C., Lane, H. Clifford

Volltext

A Randomized, Controlled, Phase II Trial Comparing Escalating Doses of Subcutaneous Interleukin-2 plus Antiretrovirals versus Antiretrovirals Alone in Human Immunodeficiency Virus—... von Losso, Marcelo H., Belloso, Waldo H., Emery, Sean, Benetucci, Jorge A., Cahn, Pedro E., Lasala, Maria C., Lopardo, Gustavo, Salomon, Horacio, Saracco, Monica, Nelson, Eileen, Law, Matthew G., Davey, Richard T., Allende, Maria C., Lane, H. Clifford

Volltext